These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37918213)

  • 1. Plasma TNF-α and phosphorylated α-syn are associated with fatigue in patients with Parkinson's disease.
    Wang L; Yi H; Liang X; Xu F; Li T; Yang X; Wei M; Ou Z; Tong Q
    J Neuroimmunol; 2023 Dec; 385():578222. PubMed ID: 37918213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
    Delgado-Alvarado M; Gago B; Gorostidi A; Jiménez-Urbieta H; Dacosta-Aguayo R; Navalpotro-Gómez I; Ruiz-Martínez J; Bergareche A; Martí-Massó JF; Martínez-Lage P; Izagirre A; Rodríguez-Oroz MC
    Mov Disord; 2017 Jul; 32(7):1066-1073. PubMed ID: 28548309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of α-Synuclein Species in Plasma Exosomes and the Oligomeric and Phosphorylated α-Synuclein as Potential Peripheral Biomarker of Parkinson's Disease.
    Zheng H; Xie Z; Zhang X; Mao J; Wang M; Wei S; Fu Y; Zheng H; He Y; Chen H; Xu Y
    Neuroscience; 2021 Aug; 469():79-90. PubMed ID: 34186110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma α-synuclein and phosphorylated tau 181 as a diagnostic biomarker panel for de novo Parkinson's disease.
    Ren J; Pan C; Wang Y; Xue C; Lin H; Xu J; Wang H; Zhang W; Xu P; Chen Y; Liu W
    J Neurochem; 2022 Jun; 161(6):506-515. PubMed ID: 35234288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylated α-synuclein in diluted human serum as a biomarker for Parkinson's disease.
    Chen WR; Chen JC; Chang SY; Chao CT; Wu YR; Chen CM; Chou C
    Biomed J; 2022 Dec; 45(6):914-922. PubMed ID: 34974168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression.
    Niu M; Li Y; Li G; Zhou L; Luo N; Yao M; Kang W; Liu J
    Eur J Neurol; 2020 Jun; 27(6):967-974. PubMed ID: 32150777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.
    Liu Z; Chan RB; Cai Z; Liu X; Wu Y; Yu Z; Feng T; Yang Y; Zhang J
    J Neuroinflammation; 2022 Feb; 19(1):53. PubMed ID: 35193594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dermal phospho-alpha-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease.
    Doppler K; Jentschke HM; Schulmeyer L; Vadasz D; Janzen A; Luster M; Höffken H; Mayer G; Brumberg J; Booij J; Musacchio T; Klebe S; Sittig-Wiegand E; Volkmann J; Sommer C; Oertel WH
    Acta Neuropathol; 2017 Apr; 133(4):535-545. PubMed ID: 28180961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and serum alpha-synuclein as a biomarker in Parkinson's disease: A meta-analysis.
    Zubelzu M; Morera-Herreras T; Irastorza G; Gómez-Esteban JC; Murueta-Goyena A
    Parkinsonism Relat Disord; 2022 Jun; 99():107-115. PubMed ID: 35717321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. α-syn and SNP rs356219 as a potential biomarker in blood for Parkinson's disease in Mexican Mestizos.
    Salas-Leal AC; Salas-Pacheco SM; Gavilán-Ceniceros JAP; Castellanos-Juárez FX; Méndez-Hernández EM; La Llave-León O; Camacho-Luis A; Quiñones-Canales G; Romero-Gutiérrez E; Arias-Carrión O; Salas-Pacheco JM; Sandoval-Carrillo AA
    Neurosci Lett; 2021 May; 754():135901. PubMed ID: 33865938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Alterations in erythrocytic oligomeric alpha-synuclein in patients with Parkinson's disease and multiple system atrophy].
    Yan XM; Li PJ; Li W; Wang XM; Yu S
    Zhonghua Yi Xue Za Zhi; 2023 Oct; 103(37):2933-2939. PubMed ID: 37752052
    [No Abstract]   [Full Text] [Related]  

  • 13. Possible inflammatory mechanisms and predictors of Parkinson's disease patients with fatigue (Brief Review).
    Wang H; Liu Y; Zhao J; Guo X; Hu M; Chen Y
    Clin Neurol Neurosurg; 2021 Sep; 208():106844. PubMed ID: 34388595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-1β/IL-1R1 signaling induced by intranasal lipopolysaccharide infusion regulates alpha-Synuclein pathology in the olfactory bulb, substantia nigra and striatum.
    Niu H; Wang Q; Zhao W; Liu J; Wang D; Muhammad B; Liu X; Quan N; Zhang H; Zhang F; Wang Y; Li H; Yang R
    Brain Pathol; 2020 Nov; 30(6):1102-1118. PubMed ID: 32678959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower Plasma α-Synuclein Levels are Associated with Cognitive Impairment in Parkinson's Disease.
    Song Z; Shen J; Liu Y; Du X; Wu Y; Liu X; Zhang J
    Clin Lab; 2021 May; 67(5):. PubMed ID: 33978361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein in salivary extracellular vesicles as a potential biomarker of Parkinson's disease.
    Cao Z; Wu Y; Liu G; Jiang Y; Wang X; Wang Z; Feng T
    Neurosci Lett; 2019 Mar; 696():114-120. PubMed ID: 30579996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High discriminatory ability of peripheral and CFSF biomarkers in Lewy body diseases.
    Bougea A; Stefanis L; Emmanouilidou E; Vekrelis K; Kapaki E
    J Neural Transm (Vienna); 2020 Mar; 127(3):311-322. PubMed ID: 31912280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Comparative Study of the Diagnostic Potential of Plasma and Erythrocytic α-Synuclein in Parkinson's Disease.
    Wang L; Wang G; Duan Y; Wang F; Lin S; Zhang F; Li H; Li A; Li H
    Neurodegener Dis; 2019; 19(5-6):204-210. PubMed ID: 32485710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of α-synuclein oligomers in red blood cells as a potential biomarker of Parkinson's disease.
    Wang X; Yu S; Li F; Feng T
    Neurosci Lett; 2015 Jul; 599():115-9. PubMed ID: 25998655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and Assessment of α-Synuclein Oligomers in the Urine of Parkinson's Disease Patients.
    Nam D; Lee JY; Lee M; Kim J; Seol W; Son I; Ho DH
    J Parkinsons Dis; 2020; 10(3):981-991. PubMed ID: 32444560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.